Produktname:4-Fluoro-2-methoxyphenylboronic acid

IUPAC Name:(4-fluoro-2-methoxyphenyl)boronic acid

CAS:179899-07-1
Molekulare Formel:C7H8BFO3
Reinheit:95%+
Katalognummer:CM133968
Molekulargewicht:169.95

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM133968-1000g in stock ȡũƎȐ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:179899-07-1
Molekulare Formel:C7H8BFO3
Schmelzpunkt:-
SMILES-Code:OB(C1=CC=C(F)C=C1OC)O
Dichte:
Katalognummer:CM133968
Molekulargewicht:169.95
Siedepunkt:
Mdl-Nr.:MFCD03788423
Lagerung:

Category Infos

Boronic Acids and Esters
Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).
Boronic Acid For Sale
Find trusted boronic acid for sale. Any requirements and problems can ask us at any time.
Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Enitociclib
On January 7, 2024, Vincerx announced promising clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination with venetoclax and prednisone for the treatment of relapsed/refractory lymphoma. Enitociclib is a highly selective CDK9 inhibitor that prevents activation of RNA polymerase II, resulting in reduction of known oncogenes MYC and MCL1.